Free Trial

Arteris (NASDAQ:AIP) Trading 9.1% Higher - Time to Buy?

Arteris logo with Computer and Technology background

Key Points

  • Arteris, Inc. saw a significant stock increase of 9.1%, closing at $14.63 after trading as high as $14.33.
  • TD Cowen raised its price target for Arteris from $12.00 to $15.00, reflecting a consensus rating of "Moderate Buy" among analysts.
  • Major shareholders, including CEO K Charles Janac, sold 50,000 shares each at an average price of $13.07, leading to a 0.51% decrease in their positions.
  • Five stocks we like better than Arteris.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) was up 9.1% on Wednesday . The stock traded as high as $14.33 and last traded at $14.63. Approximately 194,357 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 571,177 shares. The stock had previously closed at $13.40.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on AIP shares. TD Cowen increased their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Arteris in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded Arteris from a "sell" rating to a "hold" rating in a report on Monday, September 15th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $15.00.

Read Our Latest Research Report on Arteris

Arteris Trading Up 6.1%

The firm has a market cap of $606.44 million, a P/E ratio of -17.24 and a beta of 1.45. The firm has a 50-day simple moving average of $10.06 and a 200-day simple moving average of $8.69.

Arteris (NASDAQ:AIP - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). The business had revenue of $16.50 million for the quarter, compared to analysts' expectations of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Insider Transactions at Arteris

In other Arteris news, major shareholder Bayview Legacy, Llc sold 50,000 shares of Arteris stock in a transaction dated Wednesday, October 8th. The stock was sold at an average price of $13.07, for a total transaction of $653,500.00. Following the completion of the transaction, the insider owned 9,689,071 shares in the company, valued at approximately $126,636,157.97. This trade represents a 0.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO K Charles Janac sold 50,000 shares of Arteris stock in a transaction dated Wednesday, October 8th. The shares were sold at an average price of $13.07, for a total value of $653,500.00. Following the completion of the transaction, the chief executive officer owned 9,689,071 shares of the company's stock, valued at approximately $126,636,157.97. This represents a 0.51% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 811,936 shares of company stock worth $10,100,520. 33.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Arteris

Institutional investors have recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new position in shares of Arteris during the 2nd quarter worth approximately $32,000. CWM LLC raised its position in Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after purchasing an additional 10,005 shares during the period. Cambridge Investment Research Advisors Inc. purchased a new stake in Arteris in the first quarter valued at approximately $95,000. Savant Capital LLC purchased a new stake in Arteris in the second quarter valued at approximately $97,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in shares of Arteris during the second quarter worth $104,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.